Cancer as a Cause of Death among People with AIDS in the United States

Simard, Edgar P.; Engels, Eric A.
October 2010
Clinical Infectious Diseases;10/15/2010, Vol. 51 Issue 8, p957
Academic Journal
Background. People with human immunodeficiency virus (HIV) infection and AIDS have an elevated risk for cancer. Highly active antiretroviral therapy (HAART), which has been widely available since 1996, has resulted in dramatic decreases in AIDS-related deaths. Methods. We evaluated cancer as a cause of death in a US registry-based cohort of 83,282 people with AIDS (1980-2006). Causes of death due to AIDS-defining cancers (ADCs) and non-ADCs (NADCs) were assessed. We evaluated mortality rates and the fraction of deaths due to cancer. Poisson regression assessed rates according to calendar year of AIDS onset. Results. Overall mortality decreased from 302 deaths per 1000 person-years in 1980-1989, to 140 deaths per 1000 person-years in 1990-1995, and to 29 deaths per 1000 person-years in 1996-2006. ADC-related mortality decreased from 2.95 deaths per 1000 person-years in 1980-1989 to 0.65 deaths per 1000 person-years in 1996-2006 (P<.01), but the fraction of ADC-related deaths increased from 1.05% to 2.47% in association with decreases in other AIDS-related deaths. Non-Hodgkin lymphoma was the most common cancer-related cause of death (36% of deaths during 1996-2006). Likewise, NADC-related mortality decreased from 2.21 to 0.84 deaths per 1000 person-years from the period 1980-1989 to the period 1996-2006 (P<.05), but the fraction of NADC-deaths increased to 3.16% during 1996-2006. Lung cancer was the most common NADC cause of death (21% of cancer-related deaths in 1996-2006). Conclusions. Cancer-related mortality decreased in the HAART era, but because of decreasing mortality due to AIDS, cancers account for a growing fraction of deaths. Improved cancer prevention and treatment, particularly for non-Hodgkin lymphoma and lung cancer, would reduce mortality among people with AIDS.


Related Articles

  • Seven days: 7-13 November 2014.  // Nature;11/13/2014, Vol. 515 Issue 7526, p168 

    The article offers news briefs of events during November 7 to November 13, 2014. On November 7, 2014, Japan resumed nuclear power generation by restarting two reactors on the island of Kyushu. The US Department of Agriculture has decided on November 10 not to regulate the transgenic variety of...

  • Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden. Ghatnekar, Ola; Hjortsberg, Catharina; Gisslén, Magnus; Lindbäck, Stefan; Löthgren, Mickael // PharmacoEconomics;2010 Supplement, Vol. 28, p49 

    Introduction: Little is known regarding healthcare costs for HIV/AIDS patients in the era of highly active antiretroviral therapy (HAART) and subgroups of patients according to the severity and progression of HIV infection in Sweden. The objective of this study is therefore to describe the...

  • The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France. Colin, Xavier; Lafuma, Antoine; Costagliola, Dominique; Lang, Jean-Marie; Guillon, Pascal // PharmacoEconomics;2010 Supplement, Vol. 28, p59 

    Background: Highly active antiretroviral therapy (HAART) has greatly enhanced HIV management, lowering the risk of clinical disease progression and death by substantially improving HIV-induced immune deficiency. Lower CD4 cell counts have consistently been associated with higher direct costs of...

  • Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients. Hill, Andrew M.; Clotet, Bonaventura; Johnson, Margaret; Stoll, Matthias; Bellos, Nicholas; Smets, Erik // PharmacoEconomics;2010 Supplement, Vol. 28, p69 

    Background: Very few studies have evaluated the cost of highly active antiretroviral therapy (HAART) per successful treatment in HIV-infected patients. Objectives: To evaluate the cost of achieving undetectable plasma HIV-RNA levels in highly treatment-experienced, HIV-1-infected adults...

  • Malabsorption in wasting HIV disease: diagnostic and management issues in resource-poor settings. Isaac, Rita; Alex, Reginald G.; Knox, Tamsin A. // Tropical Doctor;Jul2008, Vol. 38 Issue 3, p133 

    The author reflects on the expanding number of people dying from AIDS in resource-poor countries with limited access to highly active antiretroviral therapy (HAART). The author notes that the alarming death rates is attributed to the consequence of the combines effects of opportunistic...

  • HIV Infection Late Detection in AIDS Patients of an European City with Increased Immigration Since Mid 1990s. Carnicer-Pont, Dolors; De Olalla, Patricia G.; Caylà, Joan A. // Current HIV Research;Mar2009, Vol. 7 Issue 2, p237 

    The study goal is to identify predictors of HIV infection late detection in an European city with increased immigration, and determine the effects of HAART era in HIV infection detection. We used Barcelona city AIDS registry (1987-2006). Late testers were those diagnosed of AIDS defining illness...

  • CD4 Count is Associated with Postoperative Infection in Patients with Orthopaedic Trauma who are HIV Positive. Guild, George; Moore, Thomas; Barnes, Whitney; Hermann, Christopher // Clinical Orthopaedics & Related Research;May2012, Vol. 470 Issue 5, p1507 

    Background: Since the advent of effective antiretroviral therapy, the number of people with AIDS has increased and a certain percentage of these patients will require emergent orthopaedic surgery. Little is known regarding orthopaedic infections and the association of CD4 counts with...

  • Actualização e novos desafios na coinfecção pelos vírus VIH e VHB. Valente, Cristina // RPDI - Revista Portuguesa de Doenças Infecciosas;mai-ago2013, Vol. 9 Issue 2, p66 

    Since the advent of high active anti-retroviral therapy for human immnunodeficiency virus (HIV), there has been a significant decrease in deaths related to Acquired Immunodeficiency Syndrome (AIDS) and an increase in liver-related morbidity and mortality due the co-infection with chronic...

  • HIV-1 Prevention With ART and PrEP: Mathematical Modeling Insights Into Resistance, Effectiveness, and Public Health Impact. Celum, Connie; Hallett, Timothy B.; Baeten, Jared M. // Journal of Infectious Diseases;Jul2013, Vol. 208 Issue 2, p189 

    The article offers information on the use of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for reduce the infectiousness of HIV-1–infected persons. As mentioned, the antiretroviral-based prevention, both ART and PrEP, are among the most promising strategies for reducing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics